Sponsored by: Miller Legal LLP

Find out if you qualify for a lawsuit

Contact Us:
(888) 775-3026(888) 775-3026

Januvia Overdose

A patient can overdose on Januvia just as they can overdose on any medication. Changes in heart rhythm were seen in some patients during clinical trials of Januvia. The x-rays of the heart rhythm of some patients who were given up to 800 mg of Januvia had rhythm changes called QT prolongation. Because so few patients have been reported taking an overdose of Januvia, the full consequences of an overdose are not known. In addition, the QT changes did not cause notable problems.

The consequences of an overdose depend upon a number of factors. These include:

  • How much of the medication was taken
  • Was it taken with any other medications
  • Was it taken with alcohol
  • Was it taken with any illegal drugs

The types of treatment for patients who have taken an overdose of Januvia can be:

  • Giving certain medications
  • Pumping the patient's stomach
  • Treating any symptoms that may arise (these treatments and approaches may include dialysis, giving intravenous fluids and carefully monitoring the heart)

Januvia is a medication taken by patients with Type 2 diabetes to control their levels of blood sugar.

Important Information about Januvia Risks

Some patients who have taken Januvia have developed pancreatitis, which means inflammation of the pancreas. The pancreas is a large gland located behind the stomach that secretes strong enzymes that help in digestion. Such enzymes are supposed to be activated in the duodenum or the first part of the small intestine. If they are activated prematurely in the pancreas, this can cause severe irritation to the gland. This condition can have severe consequences if not promptly treated, including kidney failure and death.

It has also been reported that taking Januvia may increase a diabetic patient's risk for developing cancer of the pancreas. There have been studies showing that more patients have developed the condition while taking Januvia and other similar Type 2 diabetes medications than those taking other medications.

Our Januvia lawyers are investigating lawsuits on behalf of patients who have been diagnosed with pancreatic cancer and who have a history taking Januvia and Byetta. To learn more, contact our attorneys today.

Januvia® (sitagliptin) is a Type 2 diabetes medication manufactured by Merck & Co., Inc. Januvia® is a registered trademark of Merck & Co., Inc.

Januvia® News

  • Januvia Sales Drop for the Quarter

    May 1st, 2013

    Sales of Merck's Januvia, a diabetes medication and the company's biggest seller, dropped for the first quarter of the year. The news, which was reported May 1, was surprising, Reuters said. Merck also lowered its full-year forecast today. Merck sales for the quarter dropped 9 percent to $10.7 billion, according to reports. That number is well below the $11.09 billion the market was expecting. The drug company... read more

  • Public Citizen Urges FDA to Ban Januvia Because of Cancer Risk

    April 15th, 2013

    Dr. Sidney Wolfe, Director of Public Citizen's Health Research Group, issued a statement last month, addressing the risk of precancerous changes in the pancreases of diabetic patients who use diabetes drugs Januvia (sitagliptin), Byetta (exenatide) and Victoza (liraglutide). According to the statement, Drs. Alexandra Butler and Peter Butler of the University of California, Los Angeles (UCLA) and colleagues published a study in the journal "Diabetes," showing... read more